pig333.com Professional Pig Community

137,814

Real users

Users

Buscar
EN
Community
Directory
Events
Training
333shop
login

This directory is for swine and general livestock companies and products from the farm to the food industry.

Ceva Santé Animale

Company Premium

264 Followers 27 Publications

Ceva Swine Franchise is committed to providing treatments and supports services to farmers, and veterinarians to prevent disease and to maintain quality of life and good health in animals, as this contributes directly to wider issue of public health and human welfare.

Injectables Non-steroidal Internal Actinobacillosis/porcine pleuropneumonia Aujeszky's disease Autogenous vaccines Circovirus/PCV Clostridiosis Influenza/flu Erysipelas Mycoplasma/Enzootic pneumonia Parvovirus PRRS Hormones

Send message

https://www.ceva.com/

10, av. de La Ballastière
France

Ceva Santé Animale

264 Followers 27 Publications

Activity Products 10 Calendar Publications 27 News 69 Sponsored articles on 333 72

1
2
3
4

Boehringer Ingelheim announces agreement with Ceva Santé Animale for the sale of certain Merial assets

Through this important step Boehringer Ingelheim aims to facilitate the approval process for Boehringer Ingelheim’s acquisition of Sanofi’s animal health business, Merial, by proactively offering up this divestiture to Ceva. Ceva will acquire certain animal health vaccines and pharmaceuticals from the Merial portfolio for swine, bovine and companion animals as well as related intellectual property, manufacturing processes and R&D activities.

Ceva posts strong double-digit organic growth once again in first half of 2016

Consolidated sales of the Ceva Group reached €455m at the end of June 2016

Ceva Acquires Biovac

Biovac, like Ceva, has experienced double-digit growth for several years as veterinarians seek alternatives to control bacterial conditions often now difficult to treat with “classic” antibiotherapy.

Ceva reports annual growth of 12% and reaffirms ambition to enter the global top 5 by 2020

Raft of new product launches across significant markets powers strong sales in 2015

1

Ceva enters European swine vaccine market with new, targeted vaccine to improve control of enzootic pneumonia

Experts meet in Barcelona to discuss new strategies to prevent the disease.

Ceva posts strong double-digit growth again in first semester 2015

Consolidated sales of the Ceva Group reached €424m at the end of June 2015, representing growth of 16% and +12% at constant perimeter and exchange rates.

Breathe Easy - Ceva focuses on supporting swine practitioners in order to improve respiratory health in swine during ESPHM congress

140 expert swine veterinarians from all over Europe attended a practical symposium organized by Ceva to help reduce respiratory disease in pigs.

Over 500 customers from all over Asia attend Ceva’s “State of the Art” seminar in Bangkok.

The topics and expert speakers were pre-selected by Ceva’s customers from the region, with 3 parallel sessions detailing “state of the art” practice in chicken, egg and swine production.

Ceva posts strong double-digit growth again in 2014

Consolidated sales of the Ceva Group reached €766m at the end of 2014, representing growth of 23%

Ceva “State of the Art” Summit at VIV Asia 2015

Ceva’s poultry, swine, services & equipment teams will focus on what is “State of the Art” in animal production during the VIV Asia international trade show to be held in Bangkok from March 11th - 13th 2015.

Ceva Santé Animale launches responsive new website

A refreshing new design and responsive features will allow users an improved browsing experience.

Ceva Santé Animale reinforces its pharmaceutical production capacity, opening a new plant at its headquarters in Libourne France

Ceva Santé Animale has invested €18 million in renovating and extending its sterile products plant in Libourne.

Ceva merges all R&D activity Dr. Steve Chu nominated as member of the Executive Committee

Ceva Santé Animale announced the appointment of Dr.Chu to its executive committee with responsibility for all R&D activities.

Mérieux Développement becomes a shareholder of Ceva Santé Animale

Ceva Santé Animale announces the arrival of a new shareholder, Mérieux Développement, the investment company of Institut Mérieux.

Ceva attracts strong investor support for 4th LMBO and returns to double-digit growth in first 6 months of 2014

Consolidated first semester sales of Ceva Group reached €366.5m at the end of June representing growth of 18.3% versus last year.

Ceva publishes latest annual report (2013) with first digital version

Global veterinary health company, Ceva Sante Animale who completed their 4th LBO deal on the 30th June published their annual report on the same day.

Ceva Santé Animale reorganizes its capital structure to bolster its international ambitions

The management of Ceva Santé Animale announces a reshaping of its capital structure through a new round of financing which strengthens its position as majority shareholder and welcomes new investors.

Ceva proposes new respiratory health programs to allow swine experts to “breathe easy”

Symposium held prior to ESPHM presents benefits of more targeted vaccination

Ceva: Co-operation to prevent zoonosis

A conference was held to facilitate the control of diseases transmissible from animals to humans.

Ceva concludes long term agreement with Jinyu Baoling to produce brucellosis vaccines in China

Ceva sealed its synergistic collaboration with partners Jinyu Baoling following the signature of a technical and trademark license to produce international standard brucellosis vaccines in China.

CEVA in APVS 2013 - The Asian Pig Veterinary Society Congress

The 6th Asian Pig Veterinary Society Congress (APVS 2013) will be held during 23rd - 25th Sept 2013 at White Palace Convention Center - 194 Hoang Van Thu st., Phu Nhuan Dist., Ho Chi Minh City, Vietnam.

1
2
3
4

Welcome to 333

Connect, share, and interact with the largest community of professionals in the swine industry.

Celebrating 137814Users on 333!

Sign up Already a member?

Recommended accounts